Abstract

BackgroundThe plant-derived omega-3 fatty acid alpha-linolenic acid (ALA) may reduce the risk of cardiovascular disease.ObjectiveWe have investigated associations between the content of ALA in adipose tissue and the risk of ischemic stroke and its subtypes.MethodsIncident cases of ischemic stroke among participants enrolled into the Danish Diet, Cancer and Health cohort (n = 57,053) were identified by linkage with the Danish National Patient Register. Subsequently, all potential cases were validated and classified into ischemic stroke subtypes. The fatty acid composition of adipose tissue was determined by gas chromatography in cases and in a randomly drawn sub-cohort (n = 3500). Statistical analyses were performed using weighted Cox regression.ResultsDuring a median of 13.4 years of follow-up, 1735 cases of total ischemic stroke were identified including 297 cases of large artery atherosclerosis, 772 cases of small-vessel occlusion, 99 cases of cardio-embolism, 91 cases with stroke of other etiology and 476 cases with stroke of undetermined etiology. The median content of ALA in adipose tissue within the sub-cohort was 0.84% (95% central range: 0.53–1.19%). Multivariable analyses showed a U-shaped association between adipose tissue content of ALA and the rate of total ischemic stroke, but this association was not statistically significant (p = 0.172). In analyses of ischemic stroke subtypes, we observed a statistically significant U-shaped association between ALA and the rate of ischemic stroke due to large artery atherosclerosis (p = 0.017), whereas no appreciable association was observed between ALA and the rate of small-vessel occlusion (p = 0.427). A positive but statistically non-significant association was observed between ALA and the rate of ischemic stroke due to cardio-embolism (p = 0.162).ConclusionsThe content of ALA in adipose tissue was statistically non-significantly U-shaped associated with risk of total ischemic stroke. For ischemic stroke subtypes a statistically significant, U-shaped association with large artery atherosclerosis was observed.

Highlights

  • Alpha-linolenic acid (ALA) is an essential fatty acid which is found mainly in plant oils, seeds and walnuts, but it can be found in varying concentrations in other foods such as green leafy vegetables, whole grain-cereals, margarines, mayonnaises, potatoes, dairyproducts and meat [1,2,3].alpha-linolenic acid (ALA) has been associated with several beneficial effects important for development of cardiovascular disease including reduced vascular inflammation [4,5], impaired platelet aggregability [6] and a reduced atherosclerotic plaque burden [7,8]

  • We examined the association between adipose tissue content of ALA and the risk of ischemic stroke in three different models

  • A total of 57,053 men and women accepted to participate in the Diet, Cancer and Health cohort study

Read more

Summary

Introduction

Alpha-linolenic acid (ALA) is an essential fatty acid which is found mainly in plant oils, seeds and walnuts, but it can be found in varying concentrations in other foods such as green leafy vegetables, whole grain-cereals, margarines, mayonnaises, potatoes, dairyproducts and meat [1,2,3].ALA has been associated with several beneficial effects important for development of cardiovascular disease including reduced vascular inflammation [4,5], impaired platelet aggregability [6] and a reduced atherosclerotic plaque burden [7,8]. Controversy remains whether ALA is associated with a lower risk of ischemic stroke. Previous observational studies investigating the association between ALA intake and the risk of ischemic stroke are sparse and have given inconsistent results [14,15,16,19,20]. One explanation may be that most previous studies did not distinguish between subtypes of ischemic stroke. This is important because ALA could play different roles in ischemic stroke subtypes due to differences in underlying etiologies. The plant-derived omega-3 fatty acid alpha-linolenic acid (ALA) may reduce the risk of cardiovascular disease

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.